相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
Yanhua Tian et al.
BIOMATERIALS (2014)
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Marcela V. Maus et al.
BLOOD (2014)
Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells
Joanne Y. H. Lim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
Nobuhiro Nishio et al.
CANCER RESEARCH (2014)
Immunotherapy for lung cancer: ongoing clinical trials
Sarah Declerck et al.
FUTURE ONCOLOGY (2014)
Exploiting the curative potential of adoptive T-cell therapy for cancer
Christian S. Hinrichs et al.
IMMUNOLOGICAL REVIEWS (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
A Cytokine-Delivering Polymer Is Effective in Reducing Tumor Burden in a Head and Neck Squamous Cell Carcinoma Murine Model
Yuan Lin et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2014)
Optogenetic control of chemokine receptor signal and T-cell migration
Yuexin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
James L. Gulley et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Abhishek D. Garg et al.
BIOFACTORS (2013)
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
Mario Sznol et al.
CLINICAL CANCER RESEARCH (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells Is Required for Their Migration into Tumors To Elicit Effective Antitumor Immunity
Rajesh Kumar Sharma et al.
JOURNAL OF IMMUNOLOGY (2013)
Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma
Atanu Mallick et al.
PLOS ONE (2013)
CD4+ T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models
Rajesh K. Sharma et al.
PLOS ONE (2013)
Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen-Specific CD8 T Cells
Eleanor Clancy-Thompson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Encouse B. Golden et al.
CANCER IMMUNOLOGY RESEARCH (2013)
CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network
Alexandre Boissonnas et al.
NEOPLASIA (2013)
Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes
Patrick Guirnalda et al.
ONCOIMMUNOLOGY (2013)
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
Matteo Bellone et al.
FRONTIERS IN ONCOLOGY (2013)
Are GPCRs Still a Source of New Targets?
Stephen L. Garland
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Absence of LTB4/BLT1 axis facilitates generation of mouse GM-CSF-induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems
Yosuke Yokota et al.
BLOOD (2012)
Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells
John J. Engelhardt et al.
CANCER CELL (2012)
Tumor-Derived Chemokine CCL5 Enhances TGF-β-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang et al.
CANCER RESEARCH (2012)
Current status of chemokine receptor inhibitors in development
Marcello Allegretti et al.
IMMUNOLOGY LETTERS (2012)
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
Helene Salmon et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Targeting TNF-α to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy
Arianna Calcinotto et al.
JOURNAL OF IMMUNOLOGY (2012)
CXCL16 and CXCR6 Are Upregulated in Psoriasis and Mediate Cutaneous Recruitment of Human CD8+ T Cells
Claudia Guenther et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Therapeutic Cancer Vaccines: Current Status and Moving Forward
Jeffrey Schlom
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Immunology beats cancer: a blueprint for successful translation
Drew M. Pardoll
NATURE IMMUNOLOGY (2012)
CD8+T Cell Migration to the Skin Requires CD4+Help in a Murine Model of Contact Hypersensitivity
Nanna Fyhrquist et al.
PLOS ONE (2012)
Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
Jun Li et al.
NEOPLASIA (2012)
Leukotriene B4 Receptor-1 Mediates Intermittent Hypoxia-induced Atherogenesis
Richard C. Li et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
Alicia Gonzalez-Martin et al.
CANCER RESEARCH (2011)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Outlining novel cellular adjuvant products for therapeutic vaccines against cancer
Josianne Nitcheu Tefit et al.
EXPERT REVIEW OF VACCINES (2011)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Deficiency of the Leukotriene B4 Receptor, BLT-1, Protects against Systemic Insulin Resistance in Diet-Induced Obesity
Matthew Spite et al.
JOURNAL OF IMMUNOLOGY (2011)
Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
Jun Li et al.
MOLECULAR THERAPY (2011)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
Rajesh K. Sharma et al.
CANCER RESEARCH (2010)
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
Davide Bedognetti et al.
EXPERT REVIEW OF VACCINES (2010)
Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8+ T Cells during Tumor Regression
Jacques Deguine et al.
IMMUNITY (2010)
Lipid-Cytokine-Chemokine Cascade Drives Neutrophil Recruitment in a Murine Model of Inflammatory Arthritis
Richard C. Chou et al.
IMMUNITY (2010)
CD8 T Cells Activated in Distinct Lymphoid Organs Differentially Express Adhesion Proteins and Coexpress Multiple Chemokine Receptors
Andrew R. Ferguson et al.
JOURNAL OF IMMUNOLOGY (2010)
Nonredundant Roles for Leukotriene B4 Receptors BLT1 and BLT2 in Inflammatory Arthritis
Steven P. Mathis et al.
JOURNAL OF IMMUNOLOGY (2010)
Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
Lynn T. Dengel et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
Verena Semmling et al.
NATURE IMMUNOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Prostate cancer as a model for tumour immunotherapy
Charles G. Drake
NATURE REVIEWS IMMUNOLOGY (2010)
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
Antonio Di Stasi et al.
BLOOD (2009)
Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
Rajesh K. Sharma et al.
CANCER RESEARCH (2009)
Intratumoral Induction of CD103 Triggers Tumor-Specific CTL Function and CCR5-Dependent T-Cell Retention
Katarzyna Franciszkiewicz et al.
CANCER RESEARCH (2009)
Selective Expression of the Chemokine Receptor XCR1 on Cross-presenting Dendritic Cells Determines Cooperation with CD8+ T Cells
Brigitte G. Dorner et al.
IMMUNITY (2009)
Differential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In Vitro
Karla J. Helbig et al.
JOURNAL OF VIROLOGY (2009)
CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help
Yusuke Nakanishi et al.
NATURE (2009)
Increased expression of Fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma
Miki Hyakudomi et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Chemokines and their receptors: Drug targets in immunity and inflammation
Antonella Viola et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
CD44 Mediates Successful Interstitial Navigation by Killer T Cells and Enables Efficient Antitumor Immunity
Paulus Mrass et al.
IMMUNITY (2008)
Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice
Beatrice Breart et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells
S. B. Justin Wong et al.
JOURNAL OF IMMUNOLOGY (2008)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Role of leukotriene B4 receptors in rheumatoid arthritis
Steven Mathis et al.
AUTOIMMUNITY REVIEWS (2007)
Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help
Yuan Zhai et al.
JOURNAL OF IMMUNOLOGY (2007)
CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity
Christine M. Freeman et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma
L. Tang et al.
GENE THERAPY (2007)
Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells
Yan Zeng et al.
CANCER RESEARCH (2007)
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
Alexandre Boissonnas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors:: a role for LTB4 in up-regulation of CCR7 expression and function
Annalisa Del Prete et al.
BLOOD (2007)
Toll-like receptor ligands energize peptide vaccines through multiple paths
Esteban Celis
CANCER RESEARCH (2007)
Random migration precedes stable target cell interactions of tumor-infiltrating T cells
Paulus Mrass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Hurdles to lymphocyte trafficking in the tumor microenvironment: Implications for effective immunotherapy
Daniel T. Fisher et al.
IMMUNOLOGICAL INVESTIGATIONS (2006)
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4 T cell-dendritic cell interaction
F Castellino et al.
NATURE (2006)
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
Anita E. M. Dirkx et al.
FASEB JOURNAL (2006)
Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/1pr lupus-prone mice
GP de Lema et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Selective infiltration of CCR5+CXCR3+ T lymphocytes in human colorectal carcinoma
H Musha et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Leukotriene B4 receptor and the function of its helix 8
T Okuno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen
A Kaiser et al.
JOURNAL OF IMMUNOLOGY (2005)
A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection
S Akashi et al.
TRANSPLANTATION (2005)
TLR3-induced activation of mast cells modulates CD81 T-cell recruitment
Z Orinska et al.
BLOOD (2005)
Autoreactive CD8+ T cells in multiple sclerosis:: a new target for therapy?
MA Friese et al.
BRAIN (2005)
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
H Xin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy
M Gough et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma
YQ Liu et al.
CLINICAL IMMUNOLOGY (2005)
Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma
Yu-Qing Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Role for CXCR6 in recruitment of activated CD8(+) lymphocytes to inflamed liver
T Sato et al.
JOURNAL OF IMMUNOLOGY (2005)
Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration
E Lavergne et al.
JOURNAL OF IMMUNOLOGY (2004)
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease
IM Mullins et al.
CANCER RESEARCH (2004)
Leukotrienes and atherosclerosis: new roles for old mediators
VR Jala et al.
TRENDS IN IMMUNOLOGY (2004)
Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment
AM Tager et al.
NATURE IMMUNOLOGY (2003)
Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues
K Goodarzi et al.
NATURE IMMUNOLOGY (2003)
Regulation of dendritic cell migration to the draining lymph node:: Impact on T lymphocyte traffic and priming
A Martín-Fontecha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
P Bousso et al.
NATURE IMMUNOLOGY (2003)
Chemokines in islet allograft rejection
R Abdi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Defective CD8 T cell memory following acute infection without CD4 T cell help
JC Sun et al.
SCIENCE (2003)
Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis
T Nanki et al.
ARTHRITIS AND RHEUMATISM (2002)
Synergistic effect of adoptive T-cell therapy and intratumoral interferon γ-inducible protein-10 transgene expression in treatment of established tumors
H Huang et al.
CELLULAR IMMUNOLOGY (2002)
Targeted disruption of the leukotriene B4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis
B Haribabu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Macrophage inflammatory protein 3α transgene attracts dendritic cells to established murine tumors and suppresses tumor growth
T Fushimi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
